arrow_back Back to App

Study on Hair Straighteners and Uterine Cancer Link

This act mandates a scientific study on the link between chemical hair straighteners and uterine cancer, with a focus on women of color. The goal is to assess product safety and potentially introduce additional testing requirements for manufacturers, which could impact the availability and composition of hair styling products.
Key points
Conducting a scientific study on the link between hair straighteners and uterine cancer, especially in women of color.
Evaluating whether the Food and Drug Administration (FDA) should impose additional testing requirements on straightener manufacturers.
Study results may influence the safety of hair products available on the market.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4396
Sponsor: Rep. Clarke, Yvette D. [D-NY-9]
Process start date: 2025-07-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Uterine Cancer Study Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4396.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-07-15.

What are the main provisions?

Key points include:

  • Conducting a scientific study on the link between hair straighteners and uterine cancer, especially in women of color.
  • Evaluating whether the Food and Drug Administration (FDA) should impose additional testing requirements on straightener manufacturers.
  • Study results may influence the safety of hair products available on the market.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Clarke, Yvette D. [D-NY-9].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health